Home/DeuterOncology/Dr Timothy Perera
DT

Dr Timothy Perera

Founder & Chief Executive Officer

DeuterOncology

Therapeutic Areas

DeuterOncology Pipeline

DrugIndicationPhase
DO-2MET-altered NSCLC & Advanced Solid TumorsPhase 1
DO-1Not specifiedPre-clinical